Covered recipient · General Payments record
TATYANA BELINSKY
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2019–2022
$4,096.24
- Reported across 305 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $375.61 | 28 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $240.18 | 19 |
| ITI, Inc. | $42.17 | 3 |
| Vanda Pharmaceuticals Inc. | $29.92 | 2 |
| Noven Therapeutics, LLC | $29.70 | 2 |
| Otsuka America Pharmaceutical, Inc. | $18.65 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.99 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2022 201920202021
Record-level detail is published for PY2022; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.51 | 01/06/2022 | Food and Beverage | Undisputed | 06/30/2026 | 890587719 | CMS |
| ABBVIE INC. | $12.11 | 01/18/2022 | Food and Beverage | Undisputed | 06/30/2026 | 890587721 | CMS |
| ABBVIE INC. | $13.66 | 01/25/2022 | Food and Beverage | Undisputed | 06/30/2026 | 890587723 | CMS |
| ABBVIE INC. | $13.52 | 01/31/2022 | Food and Beverage | Undisputed | 06/30/2026 | 890587725 | CMS |
| ABBVIE INC. | $12.60 | 01/31/2022 | Food and Beverage | Undisputed | 06/30/2026 | 890587727 | CMS |
| ABBVIE INC. | $14.71 | 02/15/2022 | Food and Beverage | Undisputed | 06/30/2026 | 890587729 | CMS |
| ABBVIE INC. | $4.86 | 03/10/2022 | Food and Beverage | Undisputed | 06/30/2026 | 890587731 | CMS |
| ABBVIE INC. | $14.70 | 03/14/2022 | Food and Beverage | Undisputed | 06/30/2026 | 890587733 | CMS |
| ABBVIE INC. | $9.67 | 03/24/2022 | Food and Beverage | Undisputed | 06/30/2026 | 890587735 | CMS |
| ABBVIE INC. | $14.24 | 03/31/2022 | Food and Beverage | Undisputed | 06/30/2026 | 890587737 | CMS |
| ABBVIE INC. | $11.32 | 03/31/2022 | Food and Beverage | Undisputed | 06/30/2026 | 890587739 | CMS |
| ABBVIE INC. | $5.48 | 04/05/2022 | Food and Beverage | Undisputed | 06/30/2026 | 890587741 | CMS |
| ABBVIE INC. | $14.95 | 04/07/2022 | Food and Beverage | Undisputed | 06/30/2026 | 890587743 | CMS |
| ABBVIE INC. | $14.73 | 04/15/2022 | Food and Beverage | Undisputed | 06/30/2026 | 890587745 | CMS |
| ABBVIE INC. | $14.87 | 04/19/2022 | Food and Beverage | Undisputed | 06/30/2026 | 890587747 | CMS |
| ABBVIE INC. | $14.87 | 04/21/2022 | Food and Beverage | Undisputed | 06/30/2026 | 890587749 | CMS |
| ABBVIE INC. | $10.00 | 05/03/2022 | Food and Beverage | Undisputed | 06/30/2026 | 890587751 | CMS |
| ABBVIE INC. | $14.71 | 05/12/2022 | Food and Beverage | Undisputed | 06/30/2026 | 890587753 | CMS |
| ABBVIE INC. | $14.67 | 05/19/2022 | Food and Beverage | Undisputed | 06/30/2026 | 890587755 | CMS |
| ITI, Inc. | $14.80 | 01/12/2022 | Food and Beverage | Undisputed | 06/30/2026 | 945660953 | CMS |
| ITI, Inc. | $13.53 | 01/26/2022 | Food and Beverage | Undisputed | 06/30/2026 | 945660955 | CMS |
| ITI, Inc. | $13.84 | 02/10/2022 | Food and Beverage | Undisputed | 06/30/2026 | 945660957 | CMS |
| Noven Therapeutics, LLC | $14.85 | 01/05/2022 | Food and Beverage | Undisputed | 06/30/2026 | 922668183 | CMS |
| Noven Therapeutics, LLC | $14.85 | 02/09/2022 | Food and Beverage | Undisputed | 06/30/2026 | 922668191 | CMS |
| Otsuka America Pharmaceutical, Inc. | $18.65 | 02/16/2022 | Food and Beverage | Undisputed | 06/30/2026 | 929256679 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.99 | 01/13/2022 | Food and Beverage | Undisputed | 06/30/2026 | 956123203 | CMS |
| Vanda Pharmaceuticals Inc. | $14.99 | 01/04/2022 | Food and Beverage | Undisputed | 06/30/2026 | 951957271 | CMS |
| Vanda Pharmaceuticals Inc. | $14.93 | 02/01/2022 | Food and Beverage | Undisputed | 06/30/2026 | 951957273 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.